Carotid and uterine vascular resistance in short-term hormone replacement therapy postmenopausal users

Maturitas

Volumn 48, Issue 4, 2004, Pages 472-478

  Lazar Jr , Felipe ^a,b   Costa Paiva, Lucia ^a   Pinto Neto, Aarão Mendes ^a   Martinez, Edson Zangiacomi ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SP Zip: 04102 001 ^*

Author keywords

Cardiovascular protection; Carotid artery; Color doppler; Estrogen; HRT; Menopause; Pulsatility index; Uterine artery

Indexed keywords

ESTRADIOL PLUS NORETHISTERONE ACETATE; PLACEBO;

ADULT; ARTERY RESISTANCE; ARTICLE; BRAZIL; CAROTID ARTERY; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OUTPATIENT; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS; UTERINE ARTERY;

ANALYSIS OF VARIANCE; BRAZIL; CAROTID ARTERIES; DOUBLE-BLIND METHOD; ENDOMETRIUM; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NORETHINDRONE; OUTPATIENTS; PLACEBOS; POSTMENOPAUSE; RESEARCH SUPPORT, NON-U.S. GOV'T; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 3242883198     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.11.003     Document Type: Article

References (30)

1. Mosca L., Collins P., Herrington D.M., Mendelsohn M.E., Pasternak R.C., Robertson R.M., et al. Hormone replacement therapy and cardiovascular disease - a statement for healthcare professionals from the American heart association. Circulation. 104:2001;499-503
2. Bush T.S., Barret-Connor E., Cowan L.D., Criqui M.H., Wallace R.B., Suchindran C.M., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the lipid research clinics program follow-up study. Circulation. 75(Suppl. 6):1987;1102-1109
3. Barret-Connor E., Wingard D.L., Criqui M.H. Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA. 262:1989;2095-2100
4. Matthews K.A., Meilahn E., Kuller L.H., Kelsey S.F., Caggiula A.W., Wing R.R. Menopause and risk factors for coronary heart disease. New Engl. J. Med. 321:1989;641-646
5. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613
6. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA. 288:2002;49-57
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
8. Fletcher M.W., Colditz G.A. Failure of estrogen plus progestin therapy for prevention. JAMA. 288:2002;366-368. [editorial]
9. Stevenson J.C., Crook D., Godsland I.F. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 98:1993;83-90
10. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. New Engl. J. Med. 316:1987;1105-1110
11. The Writing Group of The Pepi Trial. Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
12. Collins P., Beale C.M. O papel cardioprotetor da terapia de reposição hormonal (TRH) uma atualização clínica. Nova York: The Parthernon Publishing Group; 1997. p. 60.
13. Ylikorkala O., Cacciatore B., Paakkari I., Tikkanen M.J., Vinikka L., Toivonen J. The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane. Fertil. Steril. 69:1998;883-888
14. Brown A.M., Kunze D.L., Yatani A. The agonist effect of dihydropyridines on Ca channels. Nature. 311(Suppl. 11):1984;570-572
15. Collins P., Jiang C., Lindsay D., Sarrel P.M., Poole-Wilson P.A. Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet. 341:1993;1264-1265
16. Muck A.O., Seeger H., Korte K., Lippert T.H. Cardiovascular protection by postmenopausal estrogen replacement therapy: possible mechanisms of the estrogen action. Clin. Exp. Obstet. Gynecol. 21(Suppl. 3):1994;143-149
17. Gangar K.F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 338:1991;839-842
18. Hillard T.C., Bourne T.H.Ç., Whitehead M.I., Crayford T.B., Collins W.P., Campbell S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil. Steril. 58(Suppl. 5):1992;959-963
19. Penotti M., Nencioni T., Gabrielli L., Farina M., Castiglioli E., Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am. J. Obstet. Gynecol. 169:1993;1226-1232
20. Bonilla-Musoles F., Martí M.C., Ballester M.J., Raga F., Osborne N.G. Normal uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography: The effect of hormone replacement therapy. J. Ultrasound Med. 14:1995;497-501
21. Caetano J.P.J., Marques E.S., Reis P.A., Falcão J.O., Távora P.F., Camargos A.F. Evaluation of pulsatility index of the uterine arteries in menopausal women in use of transdermal estradiol: a randomized study. Fertil. Steril. 70:1998;S377-S378
22. Cacciatore B., Paakkari I., Toivonen J., Tikkanen M.J., Ylikorkala O. Randomized comparison of oral and transdermal hormone replacement on carotid and uterine resistance to blood flow. Obstet. Gynecol. 92:1998;563-568
23. Jackson S., Vyas S. A double-blind. Br. J. Obstet. Gynaecol. 105:1998;408-412
24. Lau T.K., Wan D., Yim F., Sanderson J.E., Haines C.J. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women. Fertil. Steril. 70(Suppl. 2):1998;284-288
25. Exacoustos C., Lello S., Caporale E., Minghetti M.C., Angelozzi D., Arduini D., et al. Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow Doppler: study in different phases of sequential therapy. Fertil. Steril. 71(Suppl. 3):1999;536-543
26. Özsener S., Sagol S., Oztekin K., Bilgin O. The effect of continuous combined oral estradiol and norethisterone on the renal and internal carotid artery pulsatility indices in postmenopausal women. Int. J. Gynecol. Obstet. 69:2000;281-282
27. Naessen T., Bakos O. Carotid vascular resistance in long-term estrogen users. Obstet. Gynecol. 97:2001;327-332
28. Darj E., Bakos O., Naessen T., Persson I. Ultrasonographic blood flow measurement in the carotid arteries in postmenopausal women. Gynecol. Obstet. Invest. 47:1999;20-25
29. Battaglia C., Regnani G., Artini P.G., Genazzani A.R., Primavera M.R., Salvatori M., et al. Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy. Gynecol. Endocrinol. 13:1999;223-229
30. Penotti M., Farina M., Castiglioni E., Gaffuri B., Barletta L., Gabrielli L., et al. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study. Am. J. Obstet. Gynecol. 175:1996;606-611